Medasense
Medasense offers a breakthrough technology that enables clinicians to optimize and personalize pain control and avoid overmedication.
Medasense has raised €15M across 1 funding round, most recently a Series C round in Sep 2020. Based in Ramat Gan, Israel; founded 2008; active in Software. Data as of 28 Oct 2026.
Total raised
€15M
€15,271,061
Funding rounds
1
Investors
0
distinct backers
Active since
2020-09
latest 2020-09
Funding by year
EUR raised per yearMedasense — funding by year — interactive chart.
Data table
| Medasense — funding by year | |
|---|---|
| 2020 | €15M |
Signals
Medium confidenceRaise-next likelihood10
base rate 50% for Series C
- ▼ Dormant (no round in 3+ cohort gaps)
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-09-22 | Series C | €15M | — | View deal → |
Related news
Similar companies
same sector or country- DAZN€3.8BUK · Software
- Visma€3.0BNorway · Software
- Celonis€2.2BGermany · Software
- Bending Spoons€1.7BItaly · Software
- UiPath€1.7BRomania · AI
- ContentSquare€1.3BFrance · Software
Global coverage: FundingData